(Q40977732)

25 September 2017

1 reference

title

Preventing complications in diabetes mellitus: the role of the primary care physician (English)

1 reference

25 September 2017

Laine C

1

1 reference

PubMed ID

8614181

25 September 2017

Caro JF

series ordinal

2

1 reference

25 September 2017

1 March 1996

1 reference

Medical Clinics of North America

25 September 2017

1 reference

25 September 2017

80

1 reference

25 September 2017

2

1 reference

25 September 2017

457-474

1 reference

The health and functional status of veterans with diabetes

25 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Consensus development conference on the diagnosis and management of nephropathy in patients with diabetes mellitus. American Diabetes Association and the National Kidney Foundation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Standards of medical care for patients with diabetes mellitus. American Diabetes Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Epidemiology of persistent proteinuria in type II diabetes mellitus. Population-based study in Rochester, Minnesota

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Stroke in the diabetic patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney F

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Ten-year follow-up report on Birmingham Diabetes Survey of 1961. Report by the Birmingham Diabetes Survey Working Party

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Long-term diabetic vitrectomy results. Report of 10 year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Prevention and treatment of the complications of diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

The mortality of elderly people with diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Photocoagulation for Diabetic Macular Edema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

The effect of dietary protein restriction on the progression of diabetic nephropathy. A 12-month follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Hyperglycemia, Polyol Metabolism, and Complications of Diabetes Mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

7 January 2021

Insulin use in NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

7 January 2021

Oral hypoglycemic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Diabetes, blood lipids, and the role of obesity in coronary heart disease risk for women. The Framingham study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Comparison of HbA1 and fructosamine in diagnosis of glucose-tolerance abnormalities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Undiagnosed NIDDM: clinical and public health issues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Health-insurance coverage for adults with diabetes in the U.S. population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Screening for NIDDM. Why is there no national program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Intensive conventional insulin therapy for type II diabetes. Metabolic effects during a 6-mo outpatient trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Report on a workshop to develop management recommendations for the prevention of progression in chronic renal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Impaired glucose tolerance and diabetes in obesity: a 6-year follow-up study of glucose metabolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Risk factors for progression of background retinopathy in long-standing IDDM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Duration of non-insulin-dependent diabetes and development of retinopathy: analysis of possible risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Worsening to diabetes in men with impaired glucose tolerance ("borderline diabetes")

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Risk factors for worsening to diabetes in subjects with impaired glucose tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Diabetes and cardiovascular disease. The Framingham study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

The ten-year follow-up of the Bedford survey (1962-1972): glucose tolerance and diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Trends in use of oral hypoglycemic agents 1964-1986.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Glycosylated haemoglobin as an alternative to the glucose tolerance test for the diagnosis of diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Relationship of glycosylated hemoglobin to oral glucose tolerance. Implications for diabetes screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Dietary fat predicts conversion from impaired glucose tolerance to NIDDM. The San Luis Valley Diabetes Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Diabetic retinopathy. A synthesis of perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

1990 Overview of GDM: Accomplishments of the Last Decade—Challenges for the Future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Effectiveness of glycosylated hemoglobin, fasting plasma glucose, and a single post load plasma glucose level in population screening for glucose intolerance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Hemoglobin Alc--infatuation or the real thing?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Long-term complications of diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Retinopathy in older type II diabetics. Association with glucose control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Glycosylated hemoglobin: a screening test for diabetes mellitus?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Prospective study of 352 young patients with chemical diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Impact of blood pressure and antihypertensive treatment on incipient and overt nephropathy, retinopathy, and endothelial permeability in diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Enalapril reduces microalbuminuria in young normotensive type 1 (insulin-dependent) diabetic patients irrespective of its hypotensive effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Sequential changes in serum insulin concentration during development of non-insulin-dependent diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

The natural history of impaired glucose tolerance in the Pima Indians.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Development of diabetes in Japanese subjects with impaired glucose tolerance: a seven year follow-up study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Diabetic myocardial infarction. Interaction of diabetes with other preinfarction risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Screening for diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Heart disease in patients with diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Kelly West Lecture. Primary prevention of type II diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Comparative effects of enalapril, atenolol and chlorthalidone on blood pressure and kidney function of diabetic patients affected by arterial hypertension and persistent proteinuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Closing the gap: the problem of diabetes mellitus in the United States. The Carter Center of Emory University

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

UK prospective study of therapies of maturity-onset diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Variation in office-based quality. A claims-based profile of care provided to Medicare patients with diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

A detailed study of risk factors for retinopathy and nephropathy in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Glycaemia, arterial pressure and micro-albuminuria in type 1 (insulin-dependent) diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970448-X

10.1016/S0025-7125(05)70448-X

7 January 2021

Identifiers

DOI

1 reference

25 September 2017

1 reference

PubMed ID

8614181